PharmaCyte Biotech (PMCB) Analyst & Key Data

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.45

DCF Value+453.37%

$2.49

Potential upside vs current price

Current Stock Price

$0.45

DCF Value+453.37%

$2.49

Potential upside vs current price

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.45

DCF Value+453.37%

$2.49

Potential upside vs current price

Current Stock Price

$0.45

DCF Value+453.37%

$2.49

Potential upside vs current price

PharmaCyte Biotech, Inc.